323 related articles for article (PubMed ID: 27916483)
1. Serum klotho protein levels and their correlations with the progression of type 2 diabetes mellitus.
Nie F; Wu D; Du H; Yang X; Yang M; Pang X; Xu Y
J Diabetes Complications; 2017 Mar; 31(3):594-598. PubMed ID: 27916483
[TBL] [Abstract][Full Text] [Related]
2. The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin.
Wu C; Wang Q; Lv C; Qin N; Lei S; Yuan Q; Wang G
Diabetes Res Clin Pract; 2014 Nov; 106(2):343-50. PubMed ID: 25263500
[TBL] [Abstract][Full Text] [Related]
3. Clinical implication of alterations in serum Klotho levels in patients with type 2 diabetes mellitus and its associated complications.
Zhang L; Liu T
J Diabetes Complications; 2018 Oct; 32(10):922-930. PubMed ID: 30042059
[TBL] [Abstract][Full Text] [Related]
4. Decreased plasma α-Klotho predict progression of nephropathy with type 2 diabetic patients.
Kim SS; Song SH; Kim IJ; Lee EY; Lee SM; Chung CH; Kwak IS; Lee EK; Kim YK
J Diabetes Complications; 2016 Jul; 30(5):887-92. PubMed ID: 27037042
[TBL] [Abstract][Full Text] [Related]
5. Soluble serum Klotho in diabetic nephropathy: relationship to VEGF-A.
Kacso IM; Bondor CI; Kacso G
Clin Biochem; 2012 Nov; 45(16-17):1415-20. PubMed ID: 22836100
[TBL] [Abstract][Full Text] [Related]
6. Soluble α-klotho as a novel biomarker in the early stage of nephropathy in patients with type 2 diabetes.
Lee EY; Kim SS; Lee JS; Kim IJ; Song SH; Cha SK; Park KS; Kang JS; Chung CH
PLoS One; 2014; 9(8):e102984. PubMed ID: 25084095
[TBL] [Abstract][Full Text] [Related]
7. Changes of serum Mir-217 and the correlation with the severity in type 2 diabetes patients with different stages of diabetic kidney disease.
Shao Y; Ren H; Lv C; Ma X; Wu C; Wang Q
Endocrine; 2017 Jan; 55(1):130-138. PubMed ID: 27522360
[TBL] [Abstract][Full Text] [Related]
8. Levels of Serum 25(OH)VD3, HIF-1α, VEGF, vWf, and IGF-1 and Their Correlation in Type 2 Diabetes Patients with Different Urine Albumin Creatinine Ratio.
Shao Y; Lv C; Yuan Q; Wang Q
J Diabetes Res; 2016; 2016():1925424. PubMed ID: 27069929
[TBL] [Abstract][Full Text] [Related]
9. NLRP3 expression and urinary HSP72 in relation to biomarkers of inflammation and oxidative stress in diabetic nephropathy patients.
El-Horany HE; Abd-Ellatif RN; Watany M; Hafez YM; Okda HI
IUBMB Life; 2017 Aug; 69(8):623-630. PubMed ID: 28631886
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress markers in type 2 diabetes patients with diabetic nephropathy.
Chou ST; Tseng ST
Clin Exp Nephrol; 2017 Apr; 21(2):283-292. PubMed ID: 27233502
[TBL] [Abstract][Full Text] [Related]
11. Glycated peptides are associated with the variability of endothelial dysfunction in the cerebral vessels and the kidney in type 2 diabetes mellitus patients: a cross-sectional study.
Petrica L; Vlad A; Gluhovschi G; Gadalean F; Dumitrascu V; Vlad D; Popescu R; Velciov S; Gluhovschi C; Bob F; Ursoniu S; Petrica M; Jianu DC
J Diabetes Complications; 2015 Mar; 29(2):230-7. PubMed ID: 25511877
[TBL] [Abstract][Full Text] [Related]
12. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.
Chen CC; Susanto H; Chuang WH; Liu TY; Wang CH
Cardiovasc Diabetol; 2016 Jan; 15():3. PubMed ID: 26739836
[TBL] [Abstract][Full Text] [Related]
13. Adipokine zinc-alpha-2-glycoprotein as a novel urinary biomarker presents earlier than microalbuminuria in diabetic nephropathy.
Wang Y; Li YM; Zhang S; Zhao JY; Liu CY
J Int Med Res; 2016 Apr; 44(2):278-86. PubMed ID: 26857862
[TBL] [Abstract][Full Text] [Related]
14. Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes.
Nakamura A; Shikata K; Hiramatsu M; Nakatou T; Kitamura T; Wada J; Itoshima T; Makino H
Diabetes Care; 2005 Dec; 28(12):2890-5. PubMed ID: 16306550
[TBL] [Abstract][Full Text] [Related]
15. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
Shoukry A; Bdeer Sel-A; El-Sokkary RH
Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
[TBL] [Abstract][Full Text] [Related]
16. Klotho levels: association with insulin resistance and albumin-to-creatinine ratio in type 2 diabetic patients.
Silva AP; Mendes F; Pereira L; Fragoso A; Gonçalves RB; Santos N; Rato F; Neves PL
Int Urol Nephrol; 2017 Oct; 49(10):1809-1814. PubMed ID: 28677090
[TBL] [Abstract][Full Text] [Related]
17. Association between plasma homocysteine levels and end-organ damage in newly diagnosed type 2 diabetes mellitus patients.
Kundi H; Kiziltunc E; Ates I; Cetin M; Barca AN; Ozkayar N; Ornek E
Endocr Res; 2017 Feb; 42(1):36-41. PubMed ID: 27111290
[TBL] [Abstract][Full Text] [Related]
18. Expression levels of serum vasohibin-1 and other biomarkers in type 2 diabetes mellitus patients with different urinary albumin to creatinine ratios.
Ren H; Shao Y; Ma X; Yang M; Liu Y; Wang Q
J Diabetes Complications; 2019 Jul; 33(7):477-484. PubMed ID: 31097304
[TBL] [Abstract][Full Text] [Related]
19. Circulating Levels of Soluble Klotho and Fibroblast Growth Factor 23 in Diabetic Patients and Its Association with Early Nephropathy.
Farías-Basulto A; Martínez-Ramírez HR; Gómez-García EF; Cueto-Manzano AM; Cortés-Sanabria L; Hernández-Ramos LE; Ramírez-López G; Mendoza-Carrera F
Arch Med Res; 2018 Oct; 49(7):451-455. PubMed ID: 30718148
[TBL] [Abstract][Full Text] [Related]
20. Association of plasma soluble α-klotho with pro-endothelin-1 in patients with type 2 diabetes.
Liu JJ; Liu S; Morgenthaler NG; Wong MDS; Tavintharan S; Sum CF; Lim SC
Atherosclerosis; 2014 Apr; 233(2):415-418. PubMed ID: 24530772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
